Full Paper
the starting materials had disappeared (a few minutes). After evap-
oration of the solvent under vacuum and filtration of the residue
through a short pad of silica gel, dry toluene (10 mL) was added in
a nitrogen atmosphere to the reaction mixture, which was stirred
at 908C for 4 h (6a) or 12 h (6b). Final evaporation of the solvent
and purification by column chromatography on silica gel yielded
the corresponding 2-benzo[c]azepines 6.
14.0 ppm (CH3); HRMS (EI) calcd for C29H33N [M]: 395.2613; found:
395.2616.
Experimental procedure for the preparation of 4-methoxycar-
bonyl-2,3-dihydro-1H-2-benzo[c]azepine 9a: Methanol (242 mL,
6 mmol), triethylamine (209 mL, 1.5 mmol), and iodine (171 mg,
0.675 mmol) were sequentially added to a solution of benzazepini-
um 5b (96 mg; 0.15 mmol) in THF (15 mL) at À808C. The reaction
mixture was allowed to warm to À308C, and the solvents were re-
moved under reduced pressure. Next, the residue was redissolved
in THF (15 mL) and the solution was cooled to À608C. l-Selectride
in THF (0.975 mL, 1m, 0.975 mmol) was added at this temperature
to the reaction mixture, which was allowed to warm to 08C. Finally,
the solvents were removed under reduced pressure and the resi-
due purified by column chromatography on silica gel (hexane/
ethyl acetate 20:1) to obtain benzazepine 9a (37 mg, 66%).
Experimental data for 3-cyclopropyl-5-phenyl-3H-benzo[c]aze-
pine (6a) as a model compound: Pale-yellow oil, yield=94%, Rf =
0.16 (hexane/ethyl acetate 10:1). 1H NMR (300 MHz, CDCl3, 258C,
TMS): d=8.48 (d, J(H,H)=2.1 Hz, 1H), 7.60 (dd, J(H,H)=7.0 and
1.9 Hz, 1H), 7.50–7.20 (m, 8H), 6.16 (t, J(H,H)=4.2 Hz, 1H), 2.0 (m,
1H), 1.59 (m, 1H), 0.69 (m, 2H), 0.37 ppm (m, 2H); 13C NMR
(100 MHz, CDCl3, 258C): d=160.3 (CH), 141.4 (C), 141.4 (C), 139.2
(C), 136.1 (C), 133.2 (CH), 130.1 (CH), 129.2 (CH), 129.0 (CH), 128.8
(CH), 128.2 (CH), 127.6 (CH), 126.8 (CH), 62.3 (CH), 16.6 (CH), 2.9,
(CH2), 2.2 ppm (CH2); HRMS (EI) for C19H17N [M]: 259.1361; found:
259.1355.
2-Butyl-3-isopropyl-4-methoxycarbonyl-5-phenyl-2,3-dihydro-
1H-benzo[c]azepine (9a): Colorless oil, yield=66%, Rf =0.50
1
(hexane/ethyl acetate 20:1). H NMR (300 MHz, CDCl3, 258C, TMS):
General experimental procedure for the preparation of 2,3-dihy-
dro-1H-2-benzo[c]azepines 7a,b: Trifluoromethanesulfonic acid
(27 mL, 0.3 mmol) was added over a solution of benzazepiniums
5a,c (0.25 mmol) in THF (10 mL) at 08C. After the reaction mixture
changed from red to yellow, a solution of l-selectride in THF
(33 mL, 1.0m, 0.33 mmol) was added, and the reaction mixture was
stirred at 08C for 15 min. Removal of the solvents under reduced
pressure and purification by column chromatography on silica gel
led to the isolation of 2,3-dihydro-1H-2-benzo[c]azepines 7a,b.
d=7.45–7.15 (m, 9H), 6.80 (d, J(H,H)=7.7 Hz, 1H), 3.70 (d, J(H,H)=
10.4 Hz, 1H), 3.54 (d, J(H,H)=10.4 Hz, 1H), 3.44 (s, 3H), 3.15 (d,
J(H,H)=10.1 Hz, 1H), 2.67 (m, 2H), 1.62 (m, 2H), 1.35 (m, 1H), 0.95
(t, J(H,H)=7.1 Hz, 3H), 0.86 (d, J(H,H)=6.0 Hz, 3H), 0.74 (d, J(H,H)=
5.7 Hz, 3H), 0.70 ppm (m, 1H); 13C NMR (75 MHz, CDCl3, 258C): d=
172.2 (C), 147.6 (C), 141.7 (C), 141.4 (C), 138.9 (C), 132.0 (C), 129.3
(CH), 129.2 (CH), 129.1 (CH), 128.8 (CH), 128.0 (CH), 127.9 (CH),
127.3 (CH), 69.8 (CH), 58.7 (CH2), 55.8 (CH2), 51.6 (CH3), 31.5 (CH),
30.1 (CH2), 21.0 (CH2), 20.5 (CH2), 19.9 (CH2), 14.1 ppm (CH2); HRMS
(EI) calcd for C2H2NO2 [MÀH]: 376.2277; found: 376.2278.
Experimental procedure for the preparation of 4-(piperidine-1-
carbonyl)-2,3-dihydro-1H-2-benzo[c]azepine (9b): Piperidine
(887 mL, 9 mmol), triethylamine (418 mL, 3 mmol), and iodine
(171 mg, 0.675 mmol) were sequentially added to a solution of
benzazepinium 5b in THF (15 mL, 96 mg, 0.15 mmol; À808C). The
reaction mixture was allowed to warm to À308C, and the solvents
were removed under reduced pressure. The residue was redis-
solved in methanol (15 mL) at room temperature, and sodium cya-
noborohydride (75 mg, 1.2 mmol) was added to the reaction mix-
ture, which was stirred for 1 h. Removal of the solvents under re-
duced pressure and purification by column chromatography on
silica gel (hexane/ethyl acetate 10:1) led to the isolation of benza-
zepine 9b (29 mg, 45%).
Experimental data for 2-butyl-3-cyclopropyl-5-phenyl-2,3-dihy-
dro-1H-benzo[c]azepine (7a) as a model compound: Yellowish
oil, yield=84%, Rf =0.23 (hexane/ethyl acetate 1:1). 1H NMR
(400 MHz, CDCl3, 258C, TMS): d=7.40–7.21 (m, 8H), 7.10 (m, 1H),
6.42 (d, J(H,H)=6.3 Hz, 1H), 3.76 (s, 2H), 2.88 (m, 1H), 2.59 (m, 1H),
1.87 (m, 1H), 1.65 (m, 2H), 1.41 (m, 2H), 1.05 (m, 1H), 0.99 (t,
J(H,H)=7.3 Hz, 3H), 0.65 (m, 1H), 0.57 (m, 1H), 0.25 (m, 1H),
0.10 ppm (m, 1H); 13C NMR (100 MHz, CDCl3, 258C): d=143.5 (C),
143.3 (C), 140.5 (C), 137.6 (C), 131.2 (CH), 129.9 (CH), 128.9 (CH),
128.5 (CH), 128.2 (CH), 127.6 (CH), 127.3 (CH), 127.1 (CH), 65.2 (CH),
54.2 (CH2), 50.8 (CH2), 30.2 (CH2), 20.9 (CH2), 15.0 (CH), 14.8 (CH3),
6.1 (CH2), 2.2 pm (CH2); HRMS (EI) calcd for C23H27N [M]: 317.2144;
found: 317.2145.
General experimental procedure for the preparation of 2,3-dihy-
dro-1H-2-benzo[c]azepines 8a–c: Trifluoromethanesulfonic acid
(27 mL, 0.3 mmol) was added followed by the corresponding mag-
nesium bromide (1.25 mmol; commercial solution) to a solution of
benzazepinium 5b (160 mg, 0.25 mmol) in THF (10 mL) at 208C.
After stirring the reaction mixture for 5 min, the solvents were re-
moved in vacuo and the residue purified by chromatography on
silica gel to obtain 2,3-dihydro-1H-2-benzo[c]azepines 8a–c as
single diastereoisomers.
2-Butyl-3-isopropyl-5-phenyl-4-(1-piperidinecarbonyl)-2,3-dihy-
dro-1H-benzo[c]azepine (9b): Colorless oil, yield=45%, Rf =0.19
1
(hexane/ethyl acetate 10:1). H NMR (300 MHz, CDCl3, 258C, TMS):
d=7.45–7.15 (m, 8H), 6.82 (d, J(H,H)=7.6 Hz, 1H), 3.79 (d, J(H,H)=
10.5 Hz, 1H), 3.54 (d, J(H,H)=10.5 Hz, 1H), 3.50–3.30 (m, 3H), 3.02–
2.90 (m, 3H), 2.75–2.55 (m, 2H), 1.80–1.05 (m, 8H), 0.95 (t, J(H,H)=
7.3 Hz, 3H), 0.84 (t, J(H,H)=7.6 Hz, 3H), 0.82 (d, J(H,H)=7.6 Hz,
3H), 0.76–0.58 (m, 1H), 0.57–0.40 ppm (m, 1H); 13C NMR (75 MHz,
CDCl3, 258C): d=171.3 (C), 141.8 (C), 140.8 (C), 140.6 (C), 138.6 (C),
133.4 (C), 130.3 (CH), 129.1 (CH), 129.0 (CH), 128.2 (CH), 128.1 (CH),
128.0 (CH), 127.4 (CH), 71.4 (CH), 59.0 (CH2), 56.6 (CH2), 47.4 (CH2),
42.2 (CH2), 31.8 (CH), 30.4 (CH2), 25.2 (CH2), 24.9 (CH2), 24.2 (CH2),
21.4 (CH3), 20.5 (CH2), 19.9 (CH3), 14.1 ppm (CH3); HRMS (EI) calcd
for C26H31N2O [MÀC3H7 +H]: 387.2436; found: 387.2439.
Experimental procedure for the preparation of 4-hydroxycar-
bonyl-2,3-dihydro-1H-2-benzo[c]azepine 9c: Iodine (57 mg,
0.225 mmol) was added to a solution of benzazepinium 5b in THF
(15 mL, 96 mg, 0.15 mmol; À808C), and the reaction mixture was
allowed to warm. When the mixture reached À608C, l-selectride in
THF (0.525 mL, 1m, 0.525 mmol) was added and allowed to warm
to 08C. Finally, the solvents were removed under vacuum and the
Experimental data for trans-2-butyl-1,5-diphenyl-3-isopropyl-
2,3-dihydro-1H-benzo[c]azepine (8a) as a model compound: Yel-
lowish oil, yield=74%, Rf =0.37 (hexane/ethyl acetate 40:1).
1H NMR (300 MHz, CDCl3, 258C, TMS): d=7.53 (d, J(H,H)=7.1 Hz,
2H), 7.48–7.30 (m, 8H), 7.21–6.99 (m, 3H), 6.71 (d, J(H,H)=7.4 Hz,
1H), 6.35 (d, J(H,H)=6.6 Hz, 1H), 4.95 (s, 1H), 2.95 (m, 1H), 2.50 (m,
1H), 2.36 (m, 1H), 1.99 (m, 1H), 1.59 (m, 1H), 1.40–0.85 (m, 3H),
1.07 (d, J(H,H)=6.5 Hz, 3H), 0.98 (d, J(H,H)=6.5 Hz, 3H), 0.77 ppm
(t, J(H,H)=7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3, 258C): d=142.9
(C), 142.8 (C), 142.6 (C), 140.9 (C), 140.4 (C), 133.7 (CH), 129.4 (CH),
128.8 (CH), 128.7 (CH), 128.7 (CH), 128.2 (CH), 128.0 (CH), 127.2
(CH), 126.8 (CH), 126.7 (CH), 126.1 (CH), 67.1 (CH), 65.9 (CH), 49.3
(CH2), 31.2 (CH), 30.9 (CH2), 21.0 (CH2), 20.9 (CH3), 20.6 (CH3),
&
&
Chem. Eur. J. 2014, 20, 1 – 9
6
ꢃ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!